Director/PDMR Shareholding

Summary by AI BETAClose X

Alison Jefferis, a Director at JPMorgan Emerging Markets Growth & Income plc, has notified the market of an initial transaction involving the acquisition of 533 ordinary shares at £1.4478 per share on March 19, 2026, through a Dividend Reinvestment Plan (DRIP) on the London Stock Exchange. Following this acquisition, her total holding in the company's ordinary shares of 2.5p each now stands at 18,533.

Disclaimer*

JPMorgan Emerg Mkts Growth & Income
23 March 2026
 

JPMorgan Emerging Markets Growth & Income plc

 (the 'Company')

Legal Entity Identifier: 5493001VPQDYH1SSSR77

 

Information disclosed in accordance with DTR 3.1.2-A, incorporating Article 19(1) of the Market Abuse Regulation

 

23 March 2026

1.

 

 

Details of the person discharging managerial responsibilities / persons closely associated

a)

Name

 

Alison Jefferis

2.

Reason for the notification 

a)

Position / Status

DIRECTOR

b)

Initial notification/ Amendment

INITIAL NOTIFICATION

3.

Details of the issuer

a)

Name

JPMorgan Emerging Markets Growth & Income plc

b)

Legal Identifier Code

5493001VPQDYH1SSSR77

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 2.5p each

ISIN: GB00BMXWN182

b)

Nature of the Transaction

DRIP - Acquisition of shares

c)

Price and Volume

 Price

Volume

£1.4478

533

d)

Aggregated information

-       Aggregated price

-       Price

N/A 

single transaction

e)

Total Holding following transaction

18,533 Ordinary shares

f)

Date of transaction

19 March 2026

g)

Place of transaction

London Stock Exchange, XLON






 

For further information:

 

Divya Amin

JPMorgan Funds Limited

0800 20 40 20 (or +44 1268 44 44 70)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings